- Acquired by Advanced Medical Solutions Group, Jan 2019
- Raised funding round led by Teuza, Nov 2016
About
AMS Israel develops protein-free tissue adhesives based on proprietary alga-mimetic formulations for use in a wide range of surgical applications. The company's adhesive technology mimics the underwater adherence mechanism of algae. AMS's first product, Seal-V, is a surgical sealant designed for use in various vascular procedures. Seal-V has proven to be safe, effective, cost effective, strong, biocompatible, biodegradable, and easy to use. Seal-V can adhere to both native and synthetic vessels, positioning it as a solution to control bleeding in vascular surgeries. The company's other products include Seal-G, a gastrointestinal bioresorbable sealant designed to secure gastrointestinal anastomoses to decrease lethal complications resulting from postsurgical leaks, and the Orthopedic Adhesion Barrier, an extra-articular bioresorbable gel designed to speed the recovery of injured joints by preventing tissue adhesions, thereby reducing disabling complications following surgical or nonsurgical joint injuries. AMS Israel's technology has been developed under the umbrella of the Alfred Mann Institute at the Technion. In 2018, the company received the CE mark for its Seal-G surgical sealant for gastrointestinal procedures.
Funding history · 1 round · — total
Q&A
- What is Sealantis' primary focus?
- Sealantis, also known as AMS Israel, develops protein-free tissue adhesives based on proprietary alga-mimetic formulations for various surgical applications, mimicking the underwater adherence mechanism of algae.
- When was Sealantis acquired and by whom?
- Sealantis was acquired by Advanced Medical Solutions Group in January 2019.
- What is Seal-V?
- Seal-V is Sealantis' first product, a surgical sealant designed for use in various vascular procedures to control bleeding.
- What is Seal-G and when did it receive CE mark?
- Seal-G is a gastrointestinal bioresorbable sealant designed to secure gastrointestinal anastomoses. It received the CE mark in 2018.
- What other products does Sealantis offer?
- Sealantis also offers the Orthopedic Adhesion Barrier, an extra-articular bioresorbable gel designed to prevent tissue adhesions and speed recovery of injured joints.
- Who was a lead investor in Sealantis' funding round in November 2016?
- Teuza was a lead investor in Sealantis' funding round in November 2016.
- Where was Sealantis' technology developed?
- Sealantis' technology was developed under the umbrella of the Alfred Mann Institute at the Technion.
Team · 1
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2007-1 |
|---|---|
| Employees (exact) | 31 |
| Status reason | Acquired (Inactive) by Advanced Medical Solutions Group on Jan 2019 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Advanced Medical Solutions Group 2019-01
Radar intelligence
Patents
| EPO | 5 |
|---|